From skin biopsy to neurons through a pluripotent intermediate under good manufacturing practice protocols

Stem Cells Translational Medicine

Volumn 1, Issue 1, 2012, Pages 36-43

  Karumbayaram, Saravanan ^a   Lee, Peiyee ^a   Azghadi, Soheila F ^a   Cooper, Aaron R ^a   Patterson, Michaela ^a   Kohn, Donald B ^a,b   Pyle, April ^a,b   Clark, Amander ^a,b   Byrne, James ^a   Zack, Jerome A ^a,b   Plath, Kathrin ^a,b   Lowry, William E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cellular therapy; Neural differentiation; Pluripotent stem cells; Reprogramming

Indexed keywords

XENOBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CRYOPRESERVATION; EMBRYONIC STEM CELL; GENE EXPRESSION; GLIA CELL; GOOD MANUFACTURING PRACTICE; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; KARYOTYPING; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; QUALITY CONTROL; SKIN BIOPSY; TERATOMA; ANIMAL; BIOPSY; BIOTECHNOLOGY; CELL CULTURE; CELL SEPARATION; CULTURE TECHNIQUE; CYTOLOGY; FIBROBLAST; GENE EXPRESSION REGULATION; LABORATORY; MOUSE MUTANT; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NUCLEAR REPROGRAMMING; PHYSIOLOGY; REPRODUCIBILITY; SKIN; STANDARD;

ANIMALS; BIOPSY; BIOTECHNOLOGY; CELL CULTURE TECHNIQUES; CELL SEPARATION; CELLS, CULTURED; FIBROBLASTS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GUIDELINES AS TOPIC; HUMANS; LABORATORIES; MALE; MICE; MICE, SCID; NEURAL STEM CELLS; NEUROGENESIS; NEURONS; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELLS; POLYMERASE CHAIN REACTION; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SKIN;

EID: 84863734269     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2011-0001     Document Type: Article

References (22)

1. Lowry WE, Quan WL. Roadblocks en route to the clinical application of induced pluripotent stem cells. J Cell Sci 2010;123:643-651.
2. Trounson A. New perspectives in human stem cell therapeutic research. Bmc Med 2009; 7:29.
3. Crook JM, Peura TT, Kravets L et al. The generation of six clinical-grade human embryonic stem cell lines. Cell Stem Cell 2007;1:490-494.
4. Filler G. Challenges in pediatric transplantation: the impact of chronic kidney disease and cardiovascular risk factors on long-term outcomes and recommended management strategies. Pediatr Transplant 2011;15:25-31.
5. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-872.
6. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318: 1917-1920.
7. Park IH, Zhao R, West JA et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008;451:141-146.
8. Lowry WE, Richter L, Yachechko R et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A 2008;105:2883-2888.
9. Chin MH, Mason MJ, Xie W et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression sig-natures. Cell Stem Cell 2009;5:111-123.
10. Chin MH, Pellegrini M, Plath K et al. Molecular analyses of human induced pluripotent stem cells and embryonic stem cells. Cell Stem Cell 2010;7:263-269.
11. Bock C, Kiskinis E, Verstappen G et al. Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 2011;144:439-452.
12. Rodriguez-Piza I, Richaud-Patin Y, Vassena R et al. Reprogramming of human fibro-blasts to induced pluripotent stem cells under xeno-free conditions. STEM CELLS 2010;28:36-44.
13. Ross PJ, Suhr ST, Rodriguez RM et al. Human-induced pluripotent stem cells produced under xeno-free conditions. Stem Cells Dev 2010;19:1221-1229.
14. Swistowski A, Peng J, Liu Q et al. Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions. STEM CELLS 2010; 28:1893-1904.
15. Rajala K, Lindroos B, Hussein SM et al. A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced pluripotent and adipose stem cells. PLoS One 2010;5:e10246.
16. Karumbayaram S, Novitch BG, Patterson M et al. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. STEM CELLS 2009; 27:806-811.
17. Tchieu J, Kuoy E, Chin MH et al. Female human iPSCs retain an inactive X chromosome. Cell Stem Cell 2010;7:329-342.
18. Paruzynski A, Arens A, Gabriel R et al. Genome-wide high-throughput integrome analyses by nrLAM-PCR and next-generation sequencing. Nat Protoc 2010;5:1379-1395.
19. Sommer CA, Stadtfeld M, Murphy GJ et al. Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. STEM CELLS 2009;27:543-549.
20. Cooper AR, Patel S, Senadheera S et al. Highly efficient large-scale lentiviral vector concentration by tandem tangential flow filtration. J Virol Methods 2011;177:1-9.
21. Patterson M, Chan DN, Ha I et al. Defining the nature of human pluripotent stem cell progeny. Cell Res 2011 [Epub ahead of print]
22. Muller FJ, Schuldt BM, Williams R et al. A bioinformatic assay for pluripotency in human cells. Nat Methods 2011;8:315-317